IDEX Biometrics ASA American Depositary Shares
IDBA
IDBA was delisted on the 9th of August, 2023.
4 hedge funds and large institutions have $28K invested in IDEX Biometrics ASA American Depositary Shares in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
100% more funds holding
Funds holding: 2 → 4 (+2)
33% less capital invested
Capital invested by funds: $42K → $28K (-$14K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$3.96K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.18K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$554 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Morgan Stanley
New York
| $21K | – | – | – |
|
|
2
UBS Group
Zurich,
Switzerland
| $4K | +$1.18K | +100 | +34% |
|
|
3
JP Morgan Chase
New York
| $3K | +$3.96K | +336 | New |
|
|
CS
4
Credit Suisse
Zurich,
Switzerland
| – | +$554 | +47 | New |
|
IDBA Hedge Fund Activity: Q2 2022 in Review
4 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in IDEX Biometrics ASA American Depositary Shares (IDBA) for Q2 2022, worth a combined $28K — down 33% from $42K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new IDBA positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was JP Morgan Chase, opening a new position worth an estimated $3.96K.
- 4 institutional investors held IDEX Biometrics ASA American Depositary Shares (IDBA) as of Q2 2022, up from 2 in Q1 2022.
- Funds reported $28K of IDEX Biometrics ASA American Depositary Shares stock for Q2 2022, down 33% quarter-over-quarter.
- 2 funds opened new IDEX Biometrics ASA American Depositary Shares positions in Q2 2022 and 0 closed out, a net change of +2 holders.
- The largest IDEX Biometrics ASA American Depositary Shares buyer in Q2 2022 was JP Morgan Chase, an estimated $3.96K added.
Based on aggregated 13F filings for Q2 2022.